Clinton targets Valeant price hikes in campaign appearance

Published January 28, 2016 6 Views

Rumble Shares of Valeant Pharmaceuticals International fall after Hillary Clinton posted a blog detailing exorbitant price hikes for a migraine drug made by the company. Rough Cut (No reporter narration)

... and disable advertisements! No kidding :)